Peptonic Medical
0.00 SEK
-20.00 %
Less than 1K followers
PMED
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-20.00 %
-55.56 %
-55.56 %
-59.60 %
-36.51 %
-68.25 %
-98.25 %
-99.86 %
-99.95 %
Peptonic Medical is a biomedical company that conducts research and development of pharmaceuticals and medical devices in the field of women's health. The company's vision is to offer treatments for women-specific diseases and medical conditions. For example, hormone-free products are being developed for the treatment of vaginal atrophy and vaginal dryness. Peptonic Medical has its headquarters in Bromma.
Read moreMarket cap
16.58M SEK
Turnover
303.99K SEK
Revenue
14.79M
EBIT %
-131.51 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
27/5
2026
Interim report Q1'26
10/6
2026
General meeting '26
19/8
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
PEPTONIC Medical AB: Peptonic Medical AB (publ) - Publicerar Bokslutskommuniké för 2025
PEPTONIC Medical AB: Peptonic Medical AB - Board of Directors appoints Daniel Rudeklint as interim CEO
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools